Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1987 Jan 24;294(6566):197–198. doi: 10.1136/bmj.294.6566.197

Time for action on hepatitis B immunisation.

R G Finch
PMCID: PMC1245218  PMID: 3101805

Full text

PDF
197

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler M. W., Belsey E. M., McCutchan J. A., Mindel A. Should homosexuals be vaccinated against hepatitis B virus? Cost and benefit assessment. Br Med J (Clin Res Ed) 1983 May 21;286(6378):1621–1624. doi: 10.1136/bmj.286.6378.1621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Coleman J. C., Waugh M., Dayton R. Hepatitis B antigen and antibody in a male homosexual population. Br J Vener Dis. 1977 Apr;53(2):132–134. doi: 10.1136/sti.53.2.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Flewett T. H. Can we eradicate hepatitis B? Br Med J (Clin Res Ed) 1986 Aug 16;293(6544):404–405. doi: 10.1136/bmj.293.6544.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hadler S. C., Francis D. P., Maynard J. E., Thompson S. E., Judson F. N., Echenberg D. F., Ostrow D. G., O'Malley P. M., Penley K. A., Altman N. L. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med. 1986 Jul 24;315(4):209–214. doi: 10.1056/NEJM198607243150401. [DOI] [PubMed] [Google Scholar]
  5. Kessler H., Chase R., Harris A., Jensen D., Levin S. HTLV-III antibodies after hepatitis B vaccination. Lancet. 1985 Jun 29;1(8444):1506–1507. doi: 10.1016/s0140-6736(85)92278-0. [DOI] [PubMed] [Google Scholar]
  6. Papaevangelou G., Kallinikos G., Roumeliotou A., Politou K. Risk of AIDS in recipients of hepatitis B vaccine. N Engl J Med. 1985 Feb 7;312(6):376–377. doi: 10.1056/NEJM198502073120614. [DOI] [PubMed] [Google Scholar]
  7. Perrillo R. P., Regenstein F. G., Roodman S. T. Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus. Ann Intern Med. 1986 Sep;105(3):382–383. doi: 10.7326/0003-4819-105-3-382. [DOI] [PubMed] [Google Scholar]
  8. Polakoff S. Acute viral hepatitis B: laboratory reports 1980-4. Br Med J (Clin Res Ed) 1986 Jul 5;293(6538):37–38. doi: 10.1136/bmj.293.6538.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Smedile A., Farci P., Verme G., Caredda F., Cargnel A., Caporaso N., Dentico P., Trepo C., Opolon P., Gimson A. Influence of delta infection on severity of hepatitis B. Lancet. 1982 Oct 30;2(8305):945–947. doi: 10.1016/s0140-6736(82)90156-8. [DOI] [PubMed] [Google Scholar]
  10. Stevens C. E., Taylor P. E., Rubinstein P., Ting R. C., Bodner A. J., Sarngadharan M. G., Gallo R. C. Safety of the hepatitis B vaccine. N Engl J Med. 1985 Feb 7;312(6):375–376. doi: 10.1056/NEJM198502073120613. [DOI] [PubMed] [Google Scholar]
  11. Tedder R. S., Cameron C. H., Wilson-Croome R., Howell D. R., Colgrove A., Barbara J. A. Contrasting patterns and frequency of antibodies to the surface, core, and e antigens of hepatitis B virus in blood donors and in homosexual patients. J Med Virol. 1981;6(4):323–332. doi: 10.1002/jmv.1890060407. [DOI] [PubMed] [Google Scholar]
  12. Triger D. R. Hepatitis B immunization: experience in a provincial centre. Health Trends. 1984 May;16(2):41–43. [PubMed] [Google Scholar]
  13. Woolf I. L., Williams R. Diseases of the alimentary system. Significance of persistent HBs antigenaemia. Br Med J. 1976 Oct 2;2(6039):807–808. doi: 10.1136/bmj.2.6039.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Zuckerman A. J. Priorities for immunisation against hepatitis B. Br Med J (Clin Res Ed) 1982 Mar 6;284(6317):686–688. doi: 10.1136/bmj.284.6317.686. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES